Latest Breaking News On - Vero cell platform technology - Page 1 : vimarsana.com

COVAXIN® production volumes ramped up by Bharat Biotech, by additional 200 million

COVAXIN® production volumes ramped up by Bharat Biotech, by additional 200 million
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Chiron behringVero cell platform technologyIndigenous covidAnkleshwar gujaratInactivated vero cell platform technologyAdding chiron behring

Govt approves Ankleshwar manufacturing facility for production of Covaxin

The approval to this facility will increase vaccine availability and accelerate India's vaccination programme against COVID-19, Mandaviya said.

Serum institute of india covishieldVero cell platform technologyHealth minister mansukh mandaviyaBharat biotechChiron behringInactivated vero cell platform technologySerum instituteMansukh mandaviyaCovid 19பாரத் பயோடெக்சிரோன் பெஹ்ரிங்சீரம் நிறுவனம்

How India plans to make 2 billion Covid-19 vaccine doses available by the end of 2021

How India plans to make 2 billion Covid-19 vaccine doses available by the end of 2021
indiatribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatribune.com Daily Mail and Mail on Sunday newspapers.

Uttar pradeshAndhra pradeshUnited kingdomNew delhiSankt peterburgZydus cadilaNikolay kudashevAdar poonawallaKrishna ellaBharat immunologicalsAayog vk paulVenkatesh vermaNational dairy development boardIndian immunologicals limitedBiologicals limitedMember health

Covaxin reached 30 cities in 30 days amid staff shortages : Bharat Biotech

URL copied Covaxin has reached 30 cities in the past 30 days Covaxin, India s indigenous Covid-19 vaccine, has reached 30 cities in the past 30 days, said the vaccine manufacturer Bharat Biotech in a statement on Tuesday. Among 30 cities that have received the Covaxin doses include Delhi, Kolkata, Mumbai, Chennai, Bengaluru, Kochi and Amritsar. Covaxin is one of the three vaccines that the DGCI has cleared for emergency use in India. The two others are Covishield and Sputnik V. While Covishield is the local version of Oxford-AstraZeneca COVID-19 vaccine and being manufactured by Pune-based Serum Institute of India, Sputnik V is a Russian drug.

Andhra pradeshUnited statesWest bengalTamil naduSuchitra ellaVero cell platform technologyDrug administrationSerum institute of indiaWorld health organisationImage sourceBharat biotechPune based serum instituteBiotech co founderChiron behring vaccinesInactivated vero cell platform technologyEmergency use authorization

Covid-19: India seeks to boost vaccine production; Jaishankar likely to visit US next week

Covid-19: India seeks to boost vaccine production; Jaishankar likely to visit US next week Web Report/Mumbai Filed on May 21, 2021 A report suggested that US manufacturers were keen that India opt for centralised procurement of vaccines. Even as domestic Indian producers of the Covid vaccines announce plans to boost production to meet the growing demands in the country, External affairs minister S. Jaishankar is visiting the US next week to discuss procurement of the vaccines from top American producers. Reports on Friday said Jaishankar is likely to meet top executives from Pfizer, Moderna and Johnson & Johnson to ensure availability of the vaccines to meet the widening gap between demand and supply. Domestic production has dropped sharply impacting the administration of vaccines from 3.66 million a day in mid-April to 1.48 million now.

United statesVero cell platform technologySerum indiaInactivated vero cell platform technologyUae newsDubai newsCovid 19ஒன்றுபட்டது மாநிலங்களில்சீரம் இந்தியாஏ செய்தி